US pharma major Eli Lilly today announced positive top-line results from the Phase III LIBRETTO-432 clinical trial of Retevmo ...

Swiss pharma giant Roche’s subsidiary Genentech has announced that the Phase III MAJESTY study in adults with primary ...

German generics and consumer healthcare major STADA Arzneimittel today said it has committed to investing more than 85 ...

Juvenescence, an Abu Dhabi, UAE-based clinical-stage AI-enabled biotech company developing novel medicines to extend healthy ...

US rare disease specialist Ultragenyx Pharmaceutical (Nasdaq: RARE) is cutting around 130 employees, or 10% of its workforce, ...

UK biotech Nucleome Therapeutics has appointed Dr Michelle Morrow as chief scientific officer, as it pushes ahead with a ...

Canada’s federal health minister, Marjorie Michel, has tabled the 2024-2025 Canada Health Act Annual Report in Parliament, ...

Without the pharmaceutical industry the EU trade balance would go from a surplus of 147 billion euros ($200 billion) to a 47 ...

US clinical-stage biotech Evommune has entered into a securities purchase agreement to sell 4,494,279 shares of its common ...

Japan’s Ono Pharmaceutical today announced that the US Food and Drug Administration (FDA) has accepted for filing the New ...

A late-stage biotechnology company developing oral small-molecule therapies for neurologic and gastrointestinal diseases, led ...

Japanese biosimilars and cell therapies company Kidswell Bio and Treehill Partners, a healthcare asset and corporate development advisor, today announced the creation of a new US based regenerative ...